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Abstract
This paper presents a model of human capital accumulation that
allows for feedback eﬀects between the consequences and the likelihood
of suﬀering from particular diseases and the decisions to invest in
knowledge, both in the form of schooling and on-the-job training.
I use a calibrated version of the model to estimate the long run
impact of eradicating HIV/AIDS and malaria for a number of Sub-
Saharan African countries. I ﬁnd that the eﬀect on output per worker
can be substantial
∗I thank Kyoung Jin Choi for excellent research assistance and NSF for ﬁnancial sup-
port.
11 Introduction
There is no question that health improvements have contributed to the in-
crease in the standard of living in many countries and, in particular, in less
developed countries. It is also clear that there is a price tag associated with
increasing health standards. Even though there is an intrinsic value associ-
ated with health, it is important from a policy perspective to have some sense
of the economic impact of interventions directed to improving the health sta-
tus of a population.
The literature that measures the contribution of improved health to eco-
nomic performance has not produced, so far, deﬁnitive results. The empir-
ically based studies that regress output on some measure of health tend to
ﬁnd large economic returns from health improvements (e.g. Sachs (2003)).
Since, by its very nature, that approach is subject to the possibility of signiﬁ-
cant biases it is of interest to understand the predictions of more micro based
models. The results from this approach are mixed. Some macro based mod-
els that allow for changes in population but model health improvements in
a very stylized manner ﬁnd that the economic impact of improving “health”
is either relatively modest (e.g. see Weil (2007) and Ashraf, Lester and Weil
(2008)) or directly negative (i.e. Acemoglu and Johnson (2007)). The ﬁnd-
ings of micro based studies (see the summary in Bleakley (2010)) suggest
that, in the case of some diseases (e.g. malaria and hookworm) the economic
beneﬁts of eradication are substantial.
One channel through which disease can aﬀect development that has not
been thoroughly studied is the impact of health conditions on human capital
acquisition. Existing studies consider the quantity of schooling as the only
2measure of human capital and were not designed to incorporate the eﬀects
of quality and on-the-job training.
In this paper I develop a simple model of human capital accumulation,
both in the form of schooling and on-the-job training, that can be used to
estimate the impact of changes in health conditions on human capital accu-
mulation decisions and economic performance. The aim is to study a model
that is simple enough to be manageable and, at the same time, rich enough
so that implications can be checked against micro observations. Moreover,
Is e e kam o d e ls u ﬃciently ﬂexible to capture the impact of diseases that
aﬀect the ability to learn or to work without necessarily having a large im-
pact on adult death rates (e.g. malaria), as well as infectious diseases that
signiﬁcantly aﬀect life expectancy (e.g. HIV/AIDS).
I consider three channels through which health inﬂuences human capital
accumulation. First, an individual who has a given health condition can face
a higher probability of permanent disability or death (e.g. if he is infected
with AIDS). Second, a given health status can limit an individual’s ability to
supply eﬀort (e.g. AIDS, malaria and other debilitating diseases). Finally,
some diseases (e.g. malaria or intestinal worms) have a small impact on the
probability of dying but signiﬁcantly weaken individuals –and, in particular,
children– to the point where the eﬀectiveness of investment in human capital
is diminished.
I calibrate the model using evidence from the U.S. to recover parameters
of the human capital accumulation equation, and empirical studies of the
impact of speciﬁc diseases on schooling and income to estimate how health
conditions are mapped into the parameters of the model. I then use the
3basic setting to study the beneﬁts of eradicating malaria and HIV/AIDS and
compare the outcomes with those that correspond to a standard increase in
productivity for a small sample of African economies.
Even though I view the exercise as very preliminary there are some in-
teresting results. I ﬁnd that reducing the incidence of malaria and the rate
of transmission of HIV/AIDS to one half of their current values will result,
in the long run, in an increase in output per worker between 25% and just
over 40%. This decrease in the disease environment has asymmetric eﬀects
on healthy and malarious individuals as it induces the latter to acquire pro-
portionally more years of schooling, reducing the income gap between the
two groups.
The response of schooling –a measure of quantity of human capital–
and the stock of eﬀective human capital per year of schooling –a measure of
quality– to changes in HIV/AIDS prevalence and the incidence of malaria
are very diﬀerent, with the former accounting for over 70% of the increase
in output per worker. Thus, models that ignore the quality dimension would
tend to underestimate the beneﬁcial eﬀects of reducing the incidence of dis-
ease.
I also conduct a more traditional experiment: For each country I assume
that productivity changes so that output increases by about 17%. Unlike
the case of the reduction in the incidence of diseases, the role of schooling
and quality of human capital are reversed, with the former accounting fro
about 60% of the increase in output. Thus, in this type of models, estimates
of the role of schooling drawn from episodes of growth not associated with
changes in the disease environment do not provide an accurate guide about
4the impact of improving health standards.
2 A Birds Eye View of Selected Health Indi-
cators
Even though there is consensus that HIV/AIDS and malaria are two health
conditions that signiﬁcantly aﬄict many African countries, there is much less
agreement about the fraction of individuals who are aﬀected by those condi-
tions. In Table I, I present some relatively homogeneous data on prevalence
and incidence of HIV/AIDS and an index of malaria incidence rate. The ﬁrst
two columns (from Oster (2009)) report UNAIDS estimates of prevalence and
incidence of HIV/AIDS approximately over the 1985-2007 period. More re-
cent prevalence data from UNAIDS (column labeled Prev. (III)) suggests
that the average estimates do not reﬂect in many cases the current situation.
Oster (2009) also reports prevalence and incidence estimates inferred from
mortality data (not shown here) for a subset of the countries in Table I and
the values that she ﬁnds are smaller.
Irrespective of the preferred estimate, it is safe to conclude that there is
a high degree of heterogeneity among African countries in the severity of the
HIV/AIDS epidemic and that there are many countries in which a signiﬁcant
fraction of the population is HIV/AIDS positive. If HIV/AIDS has a large
impact on productivity, the evidence is consistent with the view that the
gains from eradication can be signiﬁcant.
5Table 1
HIV/AIDS: Prevalence and Incidence Malaria
Country Prev. (I) Inc. (I) Prev. (III) Incidence Rate
Angola 1.00 0.17 2.1 0.33
Burkina Faso 1.87 0.25 1.6 0.50
Cameroon 3.79 0.56 5.1 0.34
Cent. Af. Rep. 4.43 0.66 6.3 0.43
Congo 4.37 0.56 3.9 0.42
Cote d’Ivoire 4.24 0.57 3.9 0.41
Ethiopia 1.67 0.25 2.1 0.15
Ghana 1.35 0.20 1.9 0.40
Kenya 6.57 0.96 7.8 0.18
Malawi 8.79 1.31 11.9 0.45
Mali 0.86 0.14 1.5 0.46
Mozambique 5.94 1.01 12.5 0.39
Namibia 8.12 1.32 15.3 0.27
Nigeria 1.98 0.31 3.1 0.44
Sierra Leone 0.88 0.15 1.7 0.47
South Africa 8.95 1.49 18.1 0.0004
Tanzania 5.92 0.82 6.2 0.38
Zambia 12.63 1.82 15.2 0.39
Zimbabwe 18.95 2.51 15.3 0.07
Sources: Prev (I) and Inc. (I) from Oster (2009), Prev (III) from
UNAIDS (2008), Malaria data from Korenromp (2005)
6The last column of the table presents estimates of the average number
of malaria episodes per person per year. As in the case of HIV/AIDS there
is heterogeneity in the impact which is not surprising given the signiﬁcant
inﬂuence that geographical factors have in the prevalence of the insects that
transmit the malaria bacterium. Even though the incidence rate is a measure
of exposure over a period of time it is highly correlated with the fraction of
the population in high, medium and low transmission areas. As in the case
of HIV/AIDS, malaria is a signiﬁcant health problem in a large group of
countries.
In interpreting the data it is necessary to take into account that all these
measures reﬂect a mix of natural (or exogenous) disease conditions as well
as behavioral responses and the impact of policies designed to mitigate or
eliminate their eﬀects.
3 A Simple Model of Human Capital Accu-
mulation
Any model that succeeds in explaining the link between a particular health
condition and individual decisions about how much human capital to acquire
must take into account the eﬀect of each health condition on morbidity –
which determines the cost of acquiring human capital and the rate at which
it can be utilized– and on the probability of dying or becoming totally
disabled. As a ﬁrst approximation, I will model the mortality eﬀect as a
change in the constant probability of dying. This amounts to assuming that
lifetimes are exponential which is but a crude approximation to the data.
7However, since the purpose of this paper is to describe a simple framework
that can be used to match micro and macro evidence, this seems a reasonable
ﬁrst step.
The actual impact of health on economic conditions is probably depen-
dent on the market structure and, it is possible, that markets are “more
incomplete” is less developed countries1. However, a natural benchmark is
the case in which individuals are able to invest according to their potential.
In many cases, this provides an upper bound on the impact of diseases on
human capital investment2, and it is this case that this paper discusses.
In this context, consumption and human capital accumulation decisions
can be studied separately. Thus, individuals maximize the present discounted
value of income and then choose consumption according to that value.
It is useful to separate the optimal human capital accumulation problem
in two phases: schooling and working. I identify the schooling period –whose
length is determined endogenously– as being characterized by specialization
in human capital accumulation. This extreme view, i.e. that children in
school do not work, can be shown to be inessential in closely related models.
In future work, I will explore this issue in more detail. The working period
is deﬁned by the existence of a positive supply of labor. In what follows I
work backwards to characterize the solution of the problem: I ﬁrst study the
1See, however, the work of Townsend (XXXX) that shows that family structures come
close to replicating the optimal allocation in some low income villages.
2For example, if due to incomplete markets a healthy individual cannot acquire any
schooling, then a change in his health condition cannot possibly decrease the stock of
human capital since he was at a corner. In general, very little can be said ex-ante about
the impact of relaxing one condition in a second best situation.
8problem faced by an individual who has already joined the labor force and
then I discuss the choice of schooling.
3.1 The Post-Schooling Problem
The amount of human capital that an individual wants to supply to the
market depends on his productivity as well as his chances of dying or being
permanently disabled. I ﬁrst analyze the optimal labor supply/human capital
accumulation problem of an individual who has been infected (say of AIDS)
at age τ and whose endowment of labor is υA ∈ (0,1). Let’s denote the
current level of human capital of such an individual by h. Then, the present










where the expectation is taken over the age of death, T. The assumption
of exponential lifetime implies that the probability that an individual dies
before age t is P[T ≤ t]=1−e−λAt. A simple calculation shows that the the
value function is given by
VA(h)=¯ V
0



























































where γ = γ1+γ2,ρ (λ)=r+λ, and λjdt is the probability that an individual
in state j dies in a small interval dt.
In this context two parameters summarize the impact of HIV/AIDS: life
expectancy (given by 1/λA), a n dam e a s u r ea n dt h ee ﬀective endowment of
labor of an infected individual (υA ≤ 1).
Optimal investment implies that the stock of human capital of an a year







where hH(τ) is the stock of human capital of a healthy individual who be-
comes infected at age τ. The long run stock of human capital of an infected
agent, h∗




















This expression shows the impact of the two parameters that deﬁne being
infected on human capital accumulation: decreases in life expectancy (i.e.
increases in λA) a n di nt h ee ﬀective time endowment, υA, reduce the long-
run level of human capital.
Even though the evolution of human capital is of interest in itself, it
is the eﬀective amount supplied to the market that determines the level of
10output, he
A,H(a,p).S i n c ehe
A,H(a,p)=( υA − nA,H(a,p))hA,H(a,p),as i m p l e















The problem faced by a healthy individual who has left school is very sim-
ilar. The only diﬀerence is that there are two sources of uncertainty: the time
of death –governed by the Poisson parameter λH while still in the healthy
state– and the infection probability which, over small periods of time, is
given by ηdt. It is possible to show that the value function corresponding to
the income maximization problem is
VH(h)=¯ V
0




























































11Let hH(6+s) be the stock of human capital that a healthy individual has at
the end of his schooling period (i.e. when he is 6+s years old). Then, the
stock of human capital at age a is
hH(a)=e



























Changes in the parameters aﬀecting the spread of HIV/AIDS have a signif-
icant impact on the human capital of healthy individuals. One way of sum-
marizing their eﬀect is through the elasticity of the long run level of human
capital, h∗
H with respect to the disease parameters. Simple algebra shows
















The actual values depend on our calibration but, for the subset of countries
that we look at, the ﬁrst term which is approximately equal to 13 dominates
and it yields a large response of human capital to changes in mortality.
The eﬀect of changes in the transmission rate are, given our typical pa-




















12In both cases, improvements in the disease environment induce healthy indi-
viduals to increase their investment in human capital.3
Since infected individuals could also come from the population of malar-
ious agents, their human capital stocks satisfy the obvious analogues of the
expressions corresponding to healthy individuals. In particular, eﬀective hu-






















































For future reference we note that the relevant elements of the value func-




















3See Jayachandran and Lleras-Muney (2009) for estimates of the eﬀect of changes in
life expectancy on investments in human capital.
133.2 The Schooling Decision
In this section I study the determinants of years of schooling as well as the
quantity capital at the end of the schooling period. I consider the case in
which, at the margin, individuals have to spend private resources to acquire
schooling, and they can instantaneously adjust the level of market resources
used in the production of schooling. I assume that the law of motion of
human capital during the schooling period is
˙ h(a)=( 1− ζj)zs(n(a)h(a))
γ1xs(a)
γ2,
where 1 − ζj is an indicator of the decrease in a parameter that measures
ability to learn associated with health condition j ∈ {H,M,A}. As a matter
of convention I assume that ζH =0 .
Ia l s oc o n s i d e rt h ee ﬀect of early childhood human capital. To be precise
I assume that the stock of human capital at age 6, hE, is a function of the
resources used in its production. The relationship is hE = hBx
ζ
E.

















˙ h(a)=( 1 − ζj)zsh(a)
γ1x(a)
γ2, for 6 ≤ a ≤ 6+s. (11b)
In the Appendix I show that the optimal level of human capital at the end
































The left hand side of equation (12) is increasing and concave, while the
right hand side is linear in human capital. Thus, it is possible that there
is no positive solution to this equation. This can happen, for example, if
an individual of type j has a very low ability to learn, i.e. high ζj. In that
case, the equilibrium level of human capital at age 6 is hE and the individual
chooses zero schooling.
Generically, equation (12) has two solutions. There are two constraints
that must be satisﬁed. First, no solution with h∗
j(s) <h E is a solution to
our problem since during the schooling period capital does not depreciate.
Second, the ﬁrst order condition requires that, at the equilibrium h∗
j(s), the
net marginal gain from staying in school (the left hand side of equation (12))
intersects the marginal time cost (the right hand side of equation (12)) from
above.
Inspection of this equation shows that:
1. The eﬀect of a disease that reduces ability to learn:A ni n c r e a s ei nζj
reduces h∗
j(s). If increases in ζj are viewed as the eﬀe c to fs o m eh e a l t h
condition (e.g. as a measure of days of schooling lost by a child infected
with malaria) then the human capital of an infected individual will be
lower than that of a healthy individual.
2. The eﬀect of an infectious debilitating disease: In the context of this
15model, decreases in υA –a measure of the debilitating eﬀect of HIV/AIDS–
and increases in η –the infection rate– correspond to a more severe
eﬀect of HIV/AIDS on the ability to produce. Simple algebra shows
that if λA <r+(1−γ2)/(1−γ) –a condition satisﬁed by our calibrated
values– then decreases in υA decrease h∗
j(s). The eﬀect of an increase
i nt h er a t eo fi n f e c t i o nw i t hH I V / A I D S ,η, depends on the severity of
infection. It can be shown that it unambiguously decreases the stock
of human capital when η is large. For small values of η, the right hand
side of equation (12)) pivots clockwise but, for our calibrated parame-
ters still results in a decrease in h∗
j(s). However, the eﬀect of increases
in η appear nonlinear, and they are stronger the larger the infection
rate.
3. The eﬀect of the probability of disability/death:I fj = A the right hand
side of equation (12) is increasing in ρ(λj) and increases in λj lower
the amount of human capital at the end of the schooling period. If
j ∈ {H,M} and γ2 ≤ 1/2 (as it is in the calibration) the same results
obtain for these two cases.
4. The eﬀect of economic growth: If the right hand side of equation (12)
i sd e c r e a s i n gi nt h ew a g er a t e( a si tt u r n so u tt ob ei nt h ec a l i b r a t e d
version), increases in w increase h∗
j(s).
In order to determine the implications of the model for years of schooling
–a measure of human capital with a readily available quantitative component–
it is necessary to solve for the optimal human capital accumulation policy
during the school years.
16The derivation in the Appendix shows that the solution for years of school-


















































Equations (12), (13) and 14) completely summarize the solution of the
optimal level of schooling and human capital for an individual with health
condition j. Equation (12) by itself pins down the individually optimal level of
human capital at the end of the (endogenously determined) schooling period.
Equations (13) and (14) jointly determine the shadow price of human capital
at age 6, qE, and the level of schooling, s.
3.3 The Distribution of the Population
In this section I derive the steady state distribution of the population. It
is convenient to separately keep track of the number of healthy individuals,
those who are infected with malaria (but not HIV/AIDS) and those who have
HIV/AIDS. To simplify the discussion, I analyze separately those who are
infected with HIV/AIDS who were healthy before from those who already
had malaria.
173.3.1 The Healthy and HIV/AIDS Population
I assume that healthy individuals die at the rate λH and they become infected
at the rate η. Infected individuals die at the rate λA. I concentrate on the
balanced growth distribution and assume that population is growing at a
constant rate. Thus, for example, the number of healthy individuals who are
at most a years old at time t is NH(a,t)=ΦH(a)G(t), with ˙ G(t)=gG(t)
for some g.









where BH is a measure of the birth rate of healthy individuals. Given the
steady state assumption, the previous equation is equivalent to
˙ Φ
H(a)=−(λH + g + η)Φ
H(a)+BH,




λH + g + η
(1 − e
−(λH+g+η)a).





Consider next the HIV/AIDS infected population consisting of individuals
who were previously healthy. The fraction of infected individuals who are at
most a y e a r so l dw h ow e r ei n f e c t e da ta g ep (of course, p ≤ a) at time t is
NA
H(a,p,t)=ΨA
H(a,p)G(t). This measure of the population must satisfy the






























This expression says that the relative size of the cohort of age a who became
infected at age p shrinks because of deaths (given by the exit parameter λA)







for some function ˜ ψ
A
H(p). To pin down the boundary condition, note that
ψ
A
H(p,p) is the inﬂow of individuals from the healthy population to the



































λH + g + η
19Consider next the population born with HIV/AIDS. A calculation that
parallels that for healthy individuals implies that the fraction of the popula-









where BA is a measure of the rate of individuals born with HIV/AIDS. The




3.3.2 The Malaria and HIV/AIDS Population
The evolution of the population that is infected with malaria exclusively




λM + g + η
(1 − e
−(λM+g+η)a),
where BM is a measure of individuals born (or infected early in life) with
malaria, and 1/λM is the life expectancy of an individual infected with
malaria.
Finally the density of the HIV/AIDS infected population that was previ-













λM + g + η
.








203.3.3 The Equilibrium Growth Rate
In order to determine the equilibrium growth rate it is necessary to impose
that the measures of births be consistent with birth rates. Let m(i,j)β
i
be the birth rate to an individual in state i of a child in state j, and let


















where I assume that an infected individual can give birth to a healthy child,



















λH + g + η
+
BM
λM + g + η
],
and imposing the normalization (equivalent to ﬁx i n gt h es i z eo ft h ei n i t i a l
population)
¯ Φ
H + ¯ Φ
M + ¯ Φ
A =1 ,
this system can be solved for the growth rate. Rather than describing the
more general setting, I discuss a simple but reasonable parameterization.
3.3.4 A Special Case
In order to highlight the forces at work, I will consider an interesting special
case in the rest of the paper. I assume that the birth rates and death proba-
21bilities of malarious and healthy individuals are the same4,a n dId e n o t eb y
m(H) the fraction of all births to a healthy (and a malarious) person who
are healthy. I denote by m(A) t h ef r a c t i o no fb i r t h st oa nH I V / A I D Sp o s i -
tive that result in an infected child. I assume that the distribution between
healthy and malarious is the same for HIV/AIDS and others.
Il e tβ
A =  β
H for some factor  . In the calibration below I ﬁnd that
 <1. Finally, I set Φ=¯ ΦA. With these conventions the relevant steady
s t a t ec o n d i t i o n sa r e ,
BH = m(H)β
H(1 − Φ)+m(H) β
H(1 − m(A))Φ,
BM =( 1 − m(H))β
H(1 − Φ)+( 1− m(H)) β
H(1 − m(A))Φ,
BA = m(A) β
HΦ,
and,







[1 − Φ]. (15b)
Simple manipulation of these equations show that the equilibrium level of
HIV/AIDS prevalence, Φ, a n dt h epo p u l a t i o ng r o w t hr a t e ,g,are the solutions
to the following two equations:
g = G
1(Φ) ≡ (β
H − λH)(1 − Φ)+(  β
H − λA)Φ, (16)
g = G
2(Φ) ≡ (β





4Even though death rates from malaria are higher than those for the population at
large they are much more signiﬁcant early on in life before signiﬁcant investments in
human capital have taken place.
22It is straightforward to check that the there is always a unique solution
such that Φ ∈ (0,1) and g>0. It follows that the impact of increases in
the (exogenous) demographic factors on HIV/AIDS prevalence, Φ, and the








  + +
From the perspective of the issues I am interested in, the two eﬀects
worth emphasizing are those associated with transmission of HIV/AIDS:
lower transmission rates (η), and lower rates of infection in newborns (m(A))
both decrease the prevalence of HIV/AIDS but they increase population
growth rate which, in general equilibrium has a negative impact on output
per worker.
4 Equilibrium
As a ﬁrst pass, I will study an open economy that takes the interest rate as
given. The aggregate stock of human capital available for production on a










































Proﬁt maximization requires that
r + δk + g = zFk(κ,1),
where κ is the physical-human capital ratio. It follows that
w = zFh(κ,1),





Unlike the models discussed by Young (2005), Weil (2007) and Ashraf et. al.
(2009), I assume that savings adjust so as to keep the capital-human capital
ratio equal to the user cost of capital. If the population growth rate does
not change in response to changes a health, the capital-human capital ratio
is unchanged and the change in output is completely determined by changes
in the stock of human capital and the labor force participation rate.
5C a l i b r a t i o n
This section brieﬂy describes the approach that I use to match the model with
the data. I use the parameters of the human capital accumulation technology
from Manuelli and Seshadri (2009). I assume that the technology is Cobb-
Douglas with a capital coeﬃcient equal to 1/3. The calibrated values are in
Table A.1 in the Appendix. Then, I use diﬀerent studies on the impact of
malaria and HIV/AIDS to calibrate the disease speciﬁcp a r a m e t e r .
24Population Parameters As indicated before, I assume that the birth
rates for healthy and malarious individuals are the same, that is, β
H = β
M.
As a ﬁrst pass I also assume that the probability that a child is infected
with malaria (is born malarious) is independent of the health status of the
m o t h e r . T h i si sac r u d ea p p r o x i m a t i o ns i n c ei ti sl i k e l yt h a tc o m m o ng e o -
graphical factors can result in malarious mothers having a higher proportion
of children with malaria. However, relaxing this requires access to more





Since the emphasis of the paper is on the eﬀects of human capital, it seems
reasonable to assume that λH = λM since most of the diﬀerences in mortality
associated with malaria occur early on in life before signiﬁcant investments
in human capital take place. Thus, as a ﬁrst approximation, I just ignore
this source of heterogeneity.
The fertility behavior of HIV/AIDS individuals relative to non-HIV/AIDS
agents is a controversial subject and the empirical literature has not settled
the issues related to the overall impact of the disease on birth rates. Young
(2005) argues that an increase in the prevalence of HIV/AIDS lowers fertility.
More recent analysis by Fortson (2009) and Juhn et. al. (2009) are consistent
with the view that birth rates for infected women are about 20% lower and
that the prevalence of HIV/AIDS has little impact on the fertility of healthy
25women5.T h u s ,a saﬁrst approximation, I assume
β
A =0 .80 ∗ β
H.
In order to estimate expected lifetimes of healthy individuals, λH, the
transmission rate of HIV/AIDS, η, and the fraction of children who are born
with HIV/AIDS, m(A). I use aggregate demographic data and the proportion
of all individuals who are younger than 15 years of age and have HIV/AIDS.
Life expectancy is a weighted average of the life expectancy of healthy and
infected individuals. Since the emphasis is on the eﬀect of human capital,
I use an estimate of life expectancy at age 5 rather than life expectancy at
birth since most of the investments take place after that age. Let PA be the
observed HIV/AIDS prevalence rate, and let T be life expectancy. Then,








is used to calibrate λH.
Total fertility rate per person (not woman) is the product of the instanta-
neous birth rate, β









which is used to calibrate β
H.
Assuming that the population who is HIV/AIDS at age 14 has been born








5See also the ﬁndings and the discussion in Kalemli-Ozcan (2009a) and (2009b).
26and this equation can be used to calibrate m(A).






which I use to calibrate η.
One problem with any estimate assuming that the country is in a steady
state is that, potentially, there are inconsistencies as some steady state con-
ditions are not imposed/used. In this case, I am not imposing the steady
state condition for the growth rate of population growth. To be internally
consistent (but not necessarily consistent with the calibration), I calculate
the growth rate implied by the model and the calibrated parameters as
g = β
H(1 − Φ)+0 .80 ∗ β
HΦ − λH(1 − Φ) − λAΦ.
Finally, given these estimates the model implies that the fraction of malarious
births is6
1 − m(H)=




where PM is a measure of incidence of malaria.
The results for a subset of countries are displayed in Table A.2 in the
Appendix
AIDS: Calibrating the Parameters Since the objective of this paper
is to illustrate how the model can be disciplined, I will use some simple
estimates of the parameters that are relevant. Whenever possible I double
6To be precise, 1−m(H) should be viewed as a measure of the fraction of children who
survive to age 5 who are malarious since my calibration essentially ignores what happens
before age 5.
27check the calibrated values for consistency. Salomon (2006) presents data





Using a simple average of male and females values Salomon’s data implies
Concept AFRO D AFRO E World
λA 0.10 0.094 0.08
According to Salomon, Gakidou and Murray (undated) a good approx-
imation to the distribution of death times conditional on infection is given
by the Weibull distribution. Using this distribution, the probability that an
infected individual will die before τ years after infection is
W(τ)=1− exp{−κ0τ
κ1}.
If this probability is to match the probability according to the exponential
distribution, it must be the case that
κ0τ
κ1−1 = λA.
S i n c ef o rt h er e p o r t e dp a r a m e t e r st h em e a no ft h eW e i b u l ld i s t r i b u t i o ni s1 0 ,
the estimate of λI according to this criterion would be 0.08. Finally, if instead
of matching the cumulative probability I chose to match the mean, then the
estimate of λA is 10. Young (2005) presents data on cumulative survival
rates. He shows that the probability of surviving more than 10 years after





28It seems that even though it is not clear that the data come from a steady
state distribution –and much less from an exponential– a reasonable esti-
mate of λA is somewhere between 0.08 and 0.10, with values for high infection
areas closer to the upper bound.
In addition to its impact on life expectancy HIV/AIDS can potentially
reduce an individuals ability to work. The estimates are controversial and
in many cases emphasize the loss of income in the last few years. I consider
two possible values of υA, 0.01 and 0.05 which corresponds to a decrease in
the endowment of labor of 1% and 5% respectively.
Malaria As in the case of HIV/AIDS the eﬀect of malaria is completely
summarized by two parameters: the learning ability while in schooling, 1 −
ζM, and the eﬀective endowment of labor, υM. Bleakley (2010a) estimates
the impact of eradication on average income in the U.S. around 1920 and
in Brazil, Colombia and Mexico in the 1950s. He estimates that the gains
in regional income income from complete malaria eradication are somewhere
between 10% (U.S.) and 30% (Brazil). He ﬁn d sas m a l li m p a c to ny e a r so f
schooling. A low estimate is that complete eradication increases schooling
by 0.10-0.20 years. Lucas (2010) reports the impact of a given decrease in
the prevalence of malaria on school attainment in Paraguay and Sri Lanka.
She estimates that a 10% decrease in prevalence increases schooling by 10%.
Thus, this corresponds approximately to an increase in one year of completed
schooling associated with malaria eradication.
I use the U.S. in 1920 as my basic economy since around that time malaria
was eradicated. I assume that life expectancy is 54 years and adjust the wage
29rate so that individuals choose to stay in school for 6.7 years which is an
estimate of average schooling around that time. I consider two estimates of
the impact of school attendance due to malaria: the low estimate assumes
that malaria reduces school attendance by 0.2 years, and the high estimate
that schooling decreases by a full year. The following values of the parameters
(ζM,υM) are consistent with these equilibrium changes in schooling for an
economy parameterized to mimic the U.S. in the pre eradication period.
Malaria Parameters
Calibration ζM υM
∆s = −0.2 0.003 0.93
∆s = −1.0 0.001 0.91
These calibrated parameters should be viewed as a ﬁrst (rough) approx-
imation. They imply that income of a malarious worker at age thirty one
relative to the income of a healthy worker is 14% and 23% lower in the case
of ∆s = −0.2 and ∆s = −1.0, respectively. These implications are consistent
with Bleakley’s ﬁndings even though more work is needed to understand how
malaria aﬀects age-earnings proﬁles.
6 Disease and Development
In this section I report the implications of the model for some experiments
that capture the impact of reducing the burden of disease and simple eco-
nomic development. The basic strategy is simple: I allocate to each country
its population parameters (from Table A.2) but I assume that technological
parameters are the same across countries. I then choose for each country a
30level of TFP so that the model’s predictions for output per worker coincide
with the estimate in version 6.3 of Summers-Heston Dataset. Throughout
I consider the high incidence of malaria and HIV/AIDS. To be precise, I
assume that (ζM,υ M,υA)=( 0 .001,0.91,0.95)
6.1 The Role of Human Capital
Before reviewing the predictions of the model for the impact of changes as-
sociated with health policy, it is useful to understand the channels through
which disease and economics interact. In Table 2 I present estimates of
some measures of quality and quantity of human capital. The column la-
beled ∆(h∗/s) displays the diﬀerence in human capital per year of schooling












The column labeled s∗
M/s∗
H reports the ratio of years of schooling between
malarious and healthy children given the other conditions prevailing in the
country. Finally, ¯ he/s is an index of the amount of human capital per worker
supplied to the market per year of formal schooling. Even though the units
themselves do not have an interpretation, the indicator is comparable across
countries and I normalized Ghana’s level to one.







Cameroon 1.98 0.85 0.87 1.15
Ghana 1 0.92 0.82 1.00
Kenya 1.26 0.89 0.81 0.93
Malawi 0.82 0.96 0.75 0.80
Mozambique 1.24 0.88 0.82 0.83
Zambia 1.37 0.89 0.81 0.89
Zimbabwe 1.47 0.96 0.76 0.90
In the context of this model if one individual wants to adjust his stock of
human capital there are three possible channels: years of schooling, quality
of schooling and on the job training. The results in Table 2 suggest that the
three dimensions move in the same direction. For example, a value of ∆(h∗/s)
less than one implies that the quality of schooling chosen by individuals
exposed to malaria is lower, per year of schooling, than the quality acquired
by healthy individuals. Thus, malarious individuals not only acquire fewer
years of schooling but they also have less human capital per year of schooling.
The countries in this sample diﬀer in terms of the average amount of human
capital supplied to the market per year of schooling and the ranking, with
the exception of Ghana, are positively correlated with the level of output per
worker.
326.2 Disease: Reducing HIV/AIDS Transmission
The ﬁrst exercise that I consider models the situation in which, through
behavioral or policy changes, the rate of transmission of HIV/AIDS can be
cut in half. To be precise, the experiment takes the basic estimates from the
calibrated version of the model and recomputes the equilibrium with a value
of η which is half the calibrated value.7
In Table 3, I present the predictions of the model (in the form of percent-
age changes relative to the base case) for the changes in output per worker,
∆¯ y, output per capita, ∆y, levels of schooling, (∆s,∆sH,∆sM), an indicator
of prevalence of HIV/AIDS, Φ, and the index of average human capital per
year of schooling.
Table 3. Lower Transmission Rate (%)
Country ∆¯ y ∆y ∆Φ ∆s ∆sH ∆sM ∆(¯ he/s)
Cameroon 9.2 9.6 -2.5 1.8 0.6 3.1 7.7
Ghana 4.0 4.0 -1.0 1.2 0.1 1.9 2.9
Kenya 14.2 14.4 -4.1 4.4 2.9 7.4 9.5
Malawi 19.5 17.5 -5.8 13.6 7.7 16.6 3.4
Mozambique 21.4 20.8 -6.2 9.4 5.7 10.8 10.5
Zambia 23.8 22.9 -7.3 11.6 7.3 13.4 10.2
Zimbabwe 24.3 25.1 -7.7 8.6 7.0 15.2 15.1
The eﬀects decreasing HIV/AIDS transmission on output per worker can
be quite large. In countries where HIV/AIDS does not aﬀe c tal a r g ef r a c t i o n
7Even though this is a signiﬁcant reduction it seems within the boundaries of what is
possible. McNeil (2010) reports that a vaginal gel used by women reduced the infection
rate by 39% on average and by 54% among those women who used the gel consistently.
33of the population (e.g. Ghana) the gains are modest. At the other end, in
countries with a signiﬁcant fraction of HIV/AIDS individuals in the popula-
tion the gains in output per worker exceed 30% in the long run. As a rough
approximation, the model implies that a 1% decrease in the prevalence of
HIV/AIDS through the decrease in the transmission rate increases long run
output on average by 4.0%, with the impact slightly lower for high prevalence
areas.
The impact on average schooling is a combination of increases in schooling
by healthy and malarious individuals and a change in the composition of the
population in favor of the former. In general, I ﬁnd that the increase in years
of schooling for malarious children exceed, and in some cases signiﬁcantly so,
the corresponding increase for healthy children.
The results in Table 3 suggest that even though average schooling in-
creases, this changed is dwarfed by the increase in human capital per year
of schooling. The decrease in the probability of infection has the same eﬀect
as an increase in eﬀective life expectancy which corresponds to an increase
in the utilization rate of human capital. This results in more schooling but
also higher quality and more investment in on-the-job training.
As a separate exercise I considered reducing the mother to child infection
rate to one half of the calibrated value. For this set of countries the impact
on all variables was minimal. The largest eﬀect on output per worker occurs
in Zimbabwe and it amounts to an increase in output per worker of just above
0.1%. For that reason, I do not report the results of the exercise.
346.3 Disease: Increasing Life Expectancy associated with
AIDS
T a b l e4s h o w st h ee ﬀects of doubling life expectancy for individuals that be-
come infected with HIV/AIDS. The results are in some dimensions similar to
those corresponding to lower infections rates: changes in output per worker
(in the steady state) are large for countries in which HIV/AIDS aﬀects a
signiﬁcant fraction of the population. The distributional eﬀects are also sig-
niﬁcant as malarious individuals increase their schooling more than healthy
individuals. The largest increases in human capital occur in the quantity
(schooling) dimension, as the eﬀective amount of human capital per year of
schooling, ¯ he/s, displays smaller increments.
Table 4. Higher Life Expectancy - AIDS (%)
Country ∆¯ y ∆y ∆s ∆sH ∆sM ∆(¯ he/s)
Cameroon 10.8 9.9 1.9 0.6 4.3 7.9
Ghana 4.5 4.2 1.3 0.1 2.5 2.8
Kenya 16.5 14,2 4.8 3.4 10.1 9.0
Malawi 23.5 17.0 16.1 9.3 23.2 0.8
Mozambique 26.2 20.6 11.0 6.9 15.2 8.7
Zambia 29.9 22.4 13.7 9.0 19.3 7.7
Zimbabwe 32.5 29.3 9.5 8.5 22.8 18.1
6.4 Disease: Reducing the Incidence of Malaria
Table 5 displays the predictions of the model when the incidence of malaria
among young children is reduced by one half. As equations (12), (13) and
3514) show, individual choices are not aﬀected by this policy. The only channel
t h r o u g hw h i c hi th a sa ni m p a c to no u t p u ti st h r o u g hc o m p o s i t i o ne ﬀects.
Table 5. Lower Incidence of Malaria (%)
Country ∆¯ y ∆y ∆s ∆(¯ he/s)
Cameroon 7.7 6.6 2.4 4.1
Ghana 13.3 12.1 4.6 2.7
Kenya 4.6 3.6 2.4 1.2
Malawi 9.4 6.3 8.0 0.0
Mozambique 8.4 6.0 4.9 1.1
Zambia 7.4 4.8 4.9 0.0
Zimbabwe 1.4 1.0 1.1 0.0
As expected, the largest impact is to be found in the countries in which
malaria incidence is high. From a quantitative point of view, the economic
impact is smaller than the one found for the transmission of HIV/AIDS but
still signiﬁcant. Most of the changes are associated with increases in average
schooling driven by an increase in the fraction of non-malarious individuals.
These results are consistent with a number of empirical studies that ﬁnd
positive but small eﬀects of malaria eradication.8
8See, for example, Barosfsky et. al. (2011), Bleakley (2010a), Cutler et. al (2010),
Lucas (2010). Weil (2010) is also skeptical that malaria had a large impact on African
development in the pre-colonial era. For an alternative model in which the presence of
malaria can result in multiple steady states see Gollin et. al. (2007).
366.5 Disease: Combined Eﬀect
Table 6 displays the results of jointly halving the transmission rate of HIV/AIDS,
the incidence of malaria, and the mother to child transmission.
Table 6. Combined Eﬀect (% change)
Country ∆¯ y ∆y ∆s ∆sH ∆sM ∆(¯ he/s)
Cameroon 23.9 23.1 4.0 0.5 5.2 18.5
Ghana 20.6 19.31 5.6 0.1 3.11 13.0
Kenya 29.5 28.0 7.6 3.7 12.3 19.0
Malawi 45.7 38.1 24.4 10.4 28.0 10.9
Mozambique 49.2 44.2 16.2 7.6 18.3 24.2
Zambia 52.9 46.6 19.2 9.8 22.9 23.1
Zimbabwe 47.9 47.5 11.7 8.8 26.5 32.0
The combined eﬀects on output per worker of this “better” disease envi-
ronment are large and range from 20% to over 50%. Even though keeping
in mind that these are steady state values and, hence, that discounting will
likely reduce their present value, it is hard not to view these ﬁndings as pos-
sibilities to induce economic growth in African countries. Given the constant
interest rates, the increases in output require substantial increases in capital.
Since the model is silent about domestic savings due to the constant inter-
est rate, it is possible that attaining these large gains will require signiﬁcant
capital inﬂows.
I nt e r m so ft h ed r i v e r so fe c o n o m i cg r o w t ht h er e s u l t si n d i c a t et h a tal a r g e
fraction of the increase in output per worker is associated with increases in
the quality of human capital as measured by its value per year of schooling
37(over 70%), while increases in years of education account for less than 30%
of the total change.
As in the case of the individual changes in the disease environment, the
combined eﬀect seems to have a positive eﬀect on income distribution as
measured by years of education: malarious children increase their schooling
proportionally more than healthy children and some of these diﬀerences are
substantial.
6.6 Development
In this section I explore the consequences of a 3% increase in the marginal
product of labor. In the context of this model this does not correspond to the
conventionally measured real wage since the latter is given by the product of
the marginal product of labor and the stock of human capital supplied to the
market. Since human capital is not a simple function of schooling as quality
is endogenous, adjustments for schooling do not map conventional measures
of hourly wages into marginal product. This change in the marginal product
roughly corresponds to a 2% increase in true TFP and yields increases in
output per worker of about 17%.
T h er e s u l t sa r ei nT a b l e7 .
38Table 6. Development (% change)
Country ∆¯ y ∆y ∆s ∆sH ∆sM ∆(¯ he/s)
Cameroon 16.9 13.2 7.6 7.1 8.7 2.2
Ghana 17.0 13.8 11.5 10.3 13.3 -1.0
Kenya 16.9 12.6 9.5 8.9 11.8 -0.1
Malawi 16.9 11.2 14.1 11.9 17.5 -5.4
Mozambique 16.9 12.1 9.3 8.3 10.9 -0.5
Zambia 16.9 11.3 9.8 8.7 11.8 -1.6
Zimbabwe 16.9 13.0 11.3 11.0 15.6 -1.5
There are several interesting observations. First, the quality dimension
of human capital appears less responsive to increases in productivity than
to changes in the disease environment as they account for a smaller fraction
of the increase in output per worker. Second, even an across the board pro-
ductivity change has diﬀerential impacts when it comes to schooling between
malarious and non malarious individuals. In all cases the response of years
of education to a change in the marginal product of capital is larger for the
poorer and less educated individuals. Finally, the increase in schooling re-
duces labor force participation and this implies that output per capita does
not increase as much as output per worker. The diﬀerences vary by country
and appear to be driven by demographicsa n dt h ei n i t i a ll e v e lo fs c h o o l i n g .
397 Conclusion and Directions for Further Re-
search
In this paper I developed a model that can be used to evaluate the eﬀect
of changes in the disease environment on output per worker. The version
that I discuss is very stylized and it could, and should, be adapted to speciﬁc
country and disease conditions. However, the exercise shows that it is feasible
to use micro estimates of the impact of diseases on schooling and income to
calibrate the model so that it can be used in policy analysis.
I ﬁnd that for a small sample of African economies the potential eﬀects
on output per worker of decreasing the rate of transmission of HIV/AIDS
and the incidence of malaria to half their current levels are large and range
somewhere between 20% and 50%. The model suggests that improvements
in the disease environment are not neutral and they aﬀect human capital
investment decisions diﬀerentially.
Given the preliminary nature of the exercise, it seems safe to view the
results as suggesting orders of magnitude. Nevertheless it provides an alter-
native to the conventional wisdom that disease eradication does not have a
large impact on output.
Much work remains to be done since the model, as implemented in this
draft, has limitations. First, it assumes an unrealistic distribution of life-
times. This was done to facilitate the computation and to highlight the role
of the disease parameters in inﬂuencing human capital choices. More realis-
tic representations of the disability/death eﬀects of some diseases are feasible
but require more complex models and are more computationally demanding.
40The model takes an “average” view of the eﬀects of malaria. It is relatively
straightforward to account for the intensity and frequency of malaria episodes
(details are available from the author) and this would allow to better match
the theory with the data. I hope to make progress in this direction in the
near future.
The model also abstracted away from capital market imperfections that
may limit an individual’s ability to invest in human capital for reasons un-
related to the disease environment. Incorporating this type of imperfection
is feasible but requires a more careful modeling of the role of the family as
a substitute to the market. I also considered the case in which the interest
rate is constant. However, it is possible to endogeneize it in a way that in-
corporates the eﬀect of population growth and the number of children along
the lines of Manuelli and Seshadri (2009).
The paper is salient about the welfare eﬀects since it takes changes of
the disease environment as exogenous and does not quantify its costs. For
example, even in “simple” cases like malaria, it is not always straightfor-
ward to discover the impact on health and economic outcomes of particular
interventions (see, for example, Ashraf et. al. (2010)).
The analysis was restricted to steady states but dynamics that do not
change the interest rate are feasible to model but computationally more
demanding. Last, but not least, the model can accommodate signiﬁcant
amounts of heterogeneity between individuals and regions within a country.
However, it seems best that these extensions be performed in the context of
a country and disease speciﬁc analysis.
41Appendix
Determining Human Capital The problem faced by an individual with

















˙ h(a)=( 1 − ζj)zsh(a)
γ1x(a)
γ2, for 6 ≤ a ≤ 6+s.
The Hamiltonian for this problem (before age 6+s) is simply
H = −x + q((1 − ζj)zsh
γ1x
γ2).
w h e r et h ec o s t a t ev a r i a b l es a t i s ﬁes








and that the value of the Hamiltonian at the boundary point (that is, at
age 6+s)m u s te q u a lt h en e g a t i v eo ft h ei m p a c to nt h ec o n t i n u a t i o nv a l u e .
Formally, it is given by









j h(6 + s))].
42Let the stock of human capital of an individual of type j at age 6+s
be denoted h∗




γ2, 6 ≤ a ≤ 6+s,

































which corresponds to equation (12) in the text.
The Optimal Length of Schooling Since (see Seshadri and Manuelli





ρ(λj)(a−6), for 6 ≤ a ≤ 6+s.
In particular, the number of years of schooling, s, must satisfy the a =6+s










The left hand side of this expression is known (and so is essentially, hE).
However, the shadow price of human capital at age 6, qE, needs to be de-
termined. In particular, it inﬂuences the evolution of human capital. Since,
along a solution path, it must be the case that

















The solution to the diﬀerential equation that determines the evolution of





































Since this candidate h(a) must hold for all a ∈ [6,6+s], i tm u s tt h eb et h a t
that h(6 + s)=h∗










6 − 1). (20)
Equations (20) and (19) jointly determine the equilibrium values of schooling,
s, and the shadow price of human capital at age 6, qE. Since the latter is
only needed to determine the amount invested in early childhood human
capital, it is convenient to present an expression that, given the value of
h∗
j(s) determines years of schooling. Using the value of qEh
γ1
E from equation

















































which is equation (14) in the text.
Calibration T h ec o m m o nc a l i b r a t e dv a l u e sa r e
Table A.1: Common Parameters
γ1 γ2 δh zs zh hB rα δ k
.63 .30 .018 .33 .37 1.64 .0531 .33 .071
In Table A.2 I present the estimates of the relevant population parame-
ters when I use a measure of life expectancy that is an approximation to
life expectancy conditional on reaching age 5. The column labeled ˆ g is the
internally consistent population growth rate, that is, the growth rate implied
by the model.
45Table A.2: Calibrated Population Parameters
Country T(5) λH β
H m(A) η m(H)
Angola 54 .018 .061 .149 .003 .736
Burkina Faso 58 .017 .053 .138 .002 .542
Cameroon 59 .016 .039 .218 .006 .664
Cent. Af. Rep. 58 .016 .042 .219 .007 .605
Congo 58 .017 .059 .166 .002 .642
Cote d’Ivoire 60 .016 .038 .327 .004 .596
Ethiopia 63 .016 .054 .231 .002 .870
Ghana 64 .015 .031 .216 .002 .530
Kenya 60 .016 .042 .239 .010 .774
Malawi 56 .016 .052 .196 .016 .522
Mali 58 .017 .057 .181 .002 .612
Mozambique 58 .015 .045 .152 .016 .559
Namibia 65 .013 .026 .296 .019 .551
Nigeria 58 .017 .048 .186 .004 .620
Sierra Leone 54 .018 .061 .125 .002 .682
South Africa 55 .015 .026 .210 .002 .999
Tanzania 56 .016 .048 .207 .007 .663
Zambia 52 .017 .052 .183 .020 .587
Zimbabwe 46 .019 .037 .272 .018 .916
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